Table 1. The predictive performance of our method in a series of cross-validation experiments.
Random MicroRNAs | Leave-One-Out | 50a | 100a | 150a | 200a | 250a | 300a | All microRNAs1 |
84.12%c | 85.00%c | 85.61%c | 86.10%c | 86.56%c | 86.76%c | 86.93% | ||
Ab Initio | 50a | 100a | 150a | 200a | 250a | 300a | All microRNAs1 | |
69.23%c | 68.89%c | 69.68%c | 70.00%c | 70.44%c | 71.30%c | 70.92% | ||
Random Diseases | Leave-One-Out | 90b | 100b | 110b | 120b | 130b | 140b | All diseases2 |
81.53%c | 80.66%c | 79.44%c | 83.43%c | 81.52%c | 83.47%c | 83.50% | ||
Ab Initio | 90b | 100b | 110b | 120b | 130b | 140b | All diseases2 | |
77.97%c | 77.28%c | 79.38%c | 79.27%c | 79.63%c | 79.02%c | 80.03% |
1The candidate microRNAs were obtained after deleting the microRNA (microRNAs) related to query disease.
2The candidate diseases were obtained after deleting the disease (diseases) associated with the query microRNA.
aThe number of randomly selected candidate microRNAs in microRNA prioritization.
bThe number of randomly selected candidate diseases in disease prioritization.
cThe AUC score of ROC curve.